Interestingly, PPARg2 but not SREBP1c expression was elevated in middle-aged vs. aged AHKO liver, indicating that hepatic PPARg2 was the driver of increased de novo lipogenesis and the pathogenesis of fatty liver in these mice. Here, PPARG is linked to Hepatic steatosis.